Literature DB >> 1912990

Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia.

G A Kennett1, G Curzon.   

Abstract

1. 1-3(Chlorophenyl)piperazine (mCPP) (5 mg kg-1, i.p.) inhibited 2 h food intake in rats previously deprived of food for one day. Ten 5-hydroxytryptamine (5-HT) antagonists given s.c. opposed this hypophagic response. Calculated ID50 values correlated significantly with reported affinities (r = 0.81, n = 10, P less than 0.01) for 5-HT1C but not for 5-HT2, 5-HT1A, 5-HT1B or 5-HT1D receptors. 2. ID50 values of the ten antagonists against 5-hydroxytryptophan (5-HTP) + carbidopa-induced head shakes (a 5-HT2-mediated response) correlated significantly (r = 0.81, n = 10, P less than 0.01) with their affinities for 5-HT2 but not for 5-HT1A, 5-HT1B, 5-HT1C or 5-HT1D receptors. 3. ID50 values for inhibition of hypophagia and head shakes did not correlate significantly with each other. 4. Ratios of ID50 values against hypophagia and 5-HT2-mediated head shakes gave indices of relative in vivo potencies independent of differences in drug metabolism and disposition. These ratios correlated highly significantly (r = 0.91, n = 10, P less than 0.001) with the ratios of the affinities of the drugs for 5-HT1C (but not for 5-HT1A, 5-HT1B or 5-HT1B or 5-HT1D receptors) and with their affinities for 5-HT2 receptors. These results strongly support the hypothesis that mediation of mCPP-induced hypophagia is by stimulation of 5-HT1C receptors and the mediation of 5-HTP-induced head twitches by 5-HT2 receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1912990      PMCID: PMC1908188          DOI: 10.1111/j.1476-5381.1991.tb12369.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

Review 1.  Molecular biology of 5-HT receptors.

Authors:  P R Hartig
Journal:  Trends Pharmacol Sci       Date:  1989-02       Impact factor: 14.819

2.  Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors.

Authors:  G A Kennett; G Curzon
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Quipazine reduces food intake in the rat by activation of 5-HT2-receptors.

Authors:  G Hewson; G E Leighton; R G Hill; J Hughes
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

4.  The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtype.

Authors:  E Schlicker; K Fink; M Göthert; D Hoyer; G Molderings; I Roschke; P Schoeffter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

5.  Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity.

Authors:  I Lucki; H R Ward; A Frazer
Journal:  J Pharmacol Exp Ther       Date:  1989-04       Impact factor: 4.030

6.  Anorexia induced by M-trifluoromethylphenylpiperazine (TFMPP) in rats.

Authors:  A Kłodzińska; E Chojnacka-Wójcik
Journal:  Pol J Pharmacol Pharm       Date:  1990 Jan-Feb

7.  Infusion of the 5-hydroxytryptamine agonists RU24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia.

Authors:  P H Hutson; T P Donohoe; G Curzon
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors.

Authors:  J C Neill; S J Cooper
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

9.  Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists.

Authors:  G A Kennett; P Whitton; K Shah; G Curzon
Journal:  Eur J Pharmacol       Date:  1989-05-30       Impact factor: 4.432

10.  Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.

Authors:  G A Kennett; G Curzon
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

View more
  26 in total

1.  A systematic investigation of the differential roles for ventral tegmentum serotonin 1- and 2-type receptors on food intake in the rat.

Authors:  Wayne E Pratt; Kara A Clissold; Peagan Lin; Amanda E Cain; Alexa F Ciesinski; Thomas R Hopkins; Adeolu O Ilesanmi; Erin A Kelly; Zachary Pierce-Messick; Daniel S Powell; Ian A Rosner
Journal:  Brain Res       Date:  2016-07-16       Impact factor: 3.252

Review 2.  Pharmacological profile of the 5-HT(2C) receptor agonist WAY-163909; therapeutic potential in multiple indications.

Authors:  John Dunlop; Karen L Marquis; H K Lim; Louis Leung; John Kao; Cynthia Cheesman; Sharon Rosenzweig-Lipson
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

Review 3.  Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.

Authors:  Jason C G Halford; Joanne A Harrold; Emma J Boyland; Clare L Lawton; John E Blundell
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  Central nervous control of energy and glucose balance: focus on the central melanocortin system.

Authors:  Yong Xu; Joel K Elmquist; Makoto Fukuda
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

5.  Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety.

Authors:  G A Kennett; F Bailey; D C Piper; T P Blackburn
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

6.  A comparison of the effects of the D1 receptor antagonists SCH 23390 and SCH 39166 on suppression of feeding behavior by the D1 agonist SKF38393.

Authors:  P Terry; J L Katz
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

7.  Directly Observable Behavioral Effects of Lorcaserin in Rats.

Authors:  Katherine M Serafine; Kenner C Rice; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2015-09-17       Impact factor: 4.030

8.  Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors.

Authors:  P Mazzola-Pomietto; C S Aulakh; K M Wozniak; J L Hill; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

9.  The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse.

Authors:  S M Dursun; S L Handley
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

10.  5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model.

Authors:  G A Kennett
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.